Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 1/2013

01.01.2013 | Original Article

Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study

verfasst von: Annalisa Sechi, Laura Deroma, Annunziata Lapolla, Sabrina Paci, Daniela Melis, Alberto Burlina, Francesca Carubbi, Miriam Rigoldi, Maja Di Rocco

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Life expectancy of patients with glycogen storage disease (GSD) type I has improved considerably, opening new problems correlated with adult age. In females polycystic ovaries (PCOs) has been described as frequently associated with the disease, however successful pregnancies have been reported. Whether or not GSD I is associated with impaired reproductive function is still unclear.

Patients and methods

Data about female patients with GSD Ia and Ib, who were 16 years or older, were obtained from clinical records and interviews.

Results

A total of 32 women with GSD I (25 GSD Ia, 7 GSD Ib), median age 26 years (range 16–55), were included. 9/32 patients had delayed menarche, 17/32 had irregular cycles, 8/22 had documented polycystic ovaries. Five successful spontaneous pregnancies in four patients with GSD Ia and two in a woman with GSD Ib were reported. The latter had development and enlargement of hepatic adenomas during pregnancies.

Conclusion

Despite the high prevalence of irregular menstruation cycles and polycystic ovaries, fertility seems not to be impaired in women with GSD I. During pregnancy monitoring for adenoma development is mandatory.
Literatur
Zurück zum Zitat Chen YT (2005) Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, vol 2005, 8th edn. McGraw-Hill, New York, pp 1521–1551 Chen YT (2005) Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, vol 2005, 8th edn. McGraw-Hill, New York, pp 1521–1551
Zurück zum Zitat Dagli AI, Lee PJ, Correia CE, Rodriguez C, Bhattacharya K, Steinkrauss L, Stanley CA, Weinstein DA (2010) Pregnancy in glycogen storage disease type Ib: gestational care and report of first successful deliveries. J Inherit Metab Dis. Epub ahead of print Dagli AI, Lee PJ, Correia CE, Rodriguez C, Bhattacharya K, Steinkrauss L, Stanley CA, Weinstein DA (2010) Pregnancy in glycogen storage disease type Ib: gestational care and report of first successful deliveries. J Inherit Metab Dis. Epub ahead of print
Zurück zum Zitat Däublin G, Schwahn B, Wendel U (2002) Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence. Eur J Pediatr 161(Suppl 1):S40–5PubMed Däublin G, Schwahn B, Wendel U (2002) Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence. Eur J Pediatr 161(Suppl 1):S40–5PubMed
Zurück zum Zitat Di Rocco M, Calevo MG, Taro’ M, Melis D, Allegri AE, Parenti G (2007) Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease. Mol Genet Metab 93:398–402CrossRef Di Rocco M, Calevo MG, Taro’ M, Melis D, Allegri AE, Parenti G (2007) Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease. Mol Genet Metab 93:398–402CrossRef
Zurück zum Zitat Farber M, Knuppel RA, Binkiewicz A, Kennison RD (1976) Pregnancy and von Gierke’s disease. Obstet Gynecol 47:226–8PubMed Farber M, Knuppel RA, Binkiewicz A, Kennison RD (1976) Pregnancy and von Gierke’s disease. Obstet Gynecol 47:226–8PubMed
Zurück zum Zitat Hay WW (1991) The role of placental-fetal interaction in fetal nutrition. Semin Perinatol 15:424–33PubMed Hay WW (1991) The role of placental-fetal interaction in fetal nutrition. Semin Perinatol 15:424–33PubMed
Zurück zum Zitat Johnson MP, Compton A, Drugan A, Evans MI (1990) Metabolic control of von Gierke disease (glycogen storage disease type Ia) in pregnancy: maintenance of euglycemia with cornstarch. Obstet Gynecol 75:507–10PubMed Johnson MP, Compton A, Drugan A, Evans MI (1990) Metabolic control of von Gierke disease (glycogen storage disease type Ia) in pregnancy: maintenance of euglycemia with cornstarch. Obstet Gynecol 75:507–10PubMed
Zurück zum Zitat Kent DR, Nissen ED, Nissen SE, Ziehm DJ (1978) Effect of pregnancy on liver tumor associated with oral contraceptives. Obstet Gynecol 51:148–51PubMed Kent DR, Nissen ED, Nissen SE, Ziehm DJ (1978) Effect of pregnancy on liver tumor associated with oral contraceptives. Obstet Gynecol 51:148–51PubMed
Zurück zum Zitat Lee PJ, Patel A, Hindmarsh PC, Mowat AP, Leonard JV (1995) The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with iperinsulinism. Clin Endocrinol Oxf 42:601–60PubMedCrossRef Lee PJ, Patel A, Hindmarsh PC, Mowat AP, Leonard JV (1995) The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with iperinsulinism. Clin Endocrinol Oxf 42:601–60PubMedCrossRef
Zurück zum Zitat Lee PJ, Muiesan P, Heaton N (2004) Successful pregnancy after combined renal-hepatic transplantation in glycogen storage disease type Ia. J Inherit Metab Dis 27:537–8PubMedCrossRef Lee PJ, Muiesan P, Heaton N (2004) Successful pregnancy after combined renal-hepatic transplantation in glycogen storage disease type Ia. J Inherit Metab Dis 27:537–8PubMedCrossRef
Zurück zum Zitat Lewis R, Scrutton M, Lee P, Standen GR, Murphy DJ (2004) Antenatal and intrapartum care of a pregnant woman with glycogen storage disease type 1a. Eur J Obstet Gynecol Reprod Biol 118:111–2CrossRef Lewis R, Scrutton M, Lee P, Standen GR, Murphy DJ (2004) Antenatal and intrapartum care of a pregnant woman with glycogen storage disease type 1a. Eur J Obstet Gynecol Reprod Biol 118:111–2CrossRef
Zurück zum Zitat Mairovitz V, Labrune P, Fernandez H, Audibert F, Frydman R (2002) Contraception and pregnancy in women affected by glycogen storage diseases. Eur J Pediatr 161(Suppl 1):S97–101PubMed Mairovitz V, Labrune P, Fernandez H, Audibert F, Frydman R (2002) Contraception and pregnancy in women affected by glycogen storage diseases. Eur J Pediatr 161(Suppl 1):S97–101PubMed
Zurück zum Zitat Martens DH, Rake JP, Schwarz M, Ullrich K, Weinstein DA, Merkel M, Sauer PJ, Smit GP (2008). Pregnancies in glycogen storage disease type Ia. Am J Obstet Gynecol 198:646.e1-7 Martens DH, Rake JP, Schwarz M, Ullrich K, Weinstein DA, Merkel M, Sauer PJ, Smit GP (2008). Pregnancies in glycogen storage disease type Ia. Am J Obstet Gynecol 198:646.e1-7
Zurück zum Zitat Moses SW (2002) Historical highlights and unsolved problems in glycogen storage disease type 1. Eur J Pediatr 161(Suppl 1):S2–9PubMed Moses SW (2002) Historical highlights and unsolved problems in glycogen storage disease type 1. Eur J Pediatr 161(Suppl 1):S2–9PubMed
Zurück zum Zitat Mühlhausen C, Schneppenheim R, Budde U, Merkel M, Muschol N, Ullrich K, Santer R (2005) Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type Ia. J Inherit Metab Dis 28:945–50PubMedCrossRef Mühlhausen C, Schneppenheim R, Budde U, Merkel M, Muschol N, Ullrich K, Santer R (2005) Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type Ia. J Inherit Metab Dis 28:945–50PubMedCrossRef
Zurück zum Zitat Noels JE, van Aalten SM, van der Windt DJ, Kok NF, de Man RA, Terkivatan T, Ijzermans JN (2011) Management of hepatocellular adenoma during pregnancy. J Hepatol 54:553–8PubMedCrossRef Noels JE, van Aalten SM, van der Windt DJ, Kok NF, de Man RA, Terkivatan T, Ijzermans JN (2011) Management of hepatocellular adenoma during pregnancy. J Hepatol 54:553–8PubMedCrossRef
Zurück zum Zitat Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP (2002a) Guidelines for management of glycogen storage disease type I - European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr 161(suppl):S20–S34PubMed Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP (2002a) Guidelines for management of glycogen storage disease type I - European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr 161(suppl):S20–S34PubMed
Zurück zum Zitat Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP (2002b) Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr 161(Suppl 1):S20–34PubMed Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP (2002b) Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr 161(Suppl 1):S20–34PubMed
Zurück zum Zitat Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW Jr (1979) Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242:644–8PubMedCrossRef Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW Jr (1979) Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242:644–8PubMedCrossRef
Zurück zum Zitat Ryan IP, Havel RJ, Laros RK (1994) Three consecutive pregnancies in a patient with glycogen storage disease type IA (von Gierke’s disease). Am J Obstet Gynecol 170:1687–90. Discussion 1690–91 Ryan IP, Havel RJ, Laros RK (1994) Three consecutive pregnancies in a patient with glycogen storage disease type IA (von Gierke’s disease). Am J Obstet Gynecol 170:1687–90. Discussion 1690–91
Zurück zum Zitat Talente GM, Coleman RA, Alter C, Baker L, Brown BI, Cannon RA, Chen YT, Crigler JF Jr, Ferriera P, Haworth JC, Herman GE, Isseman RM, Keating JP, Linde R, Roe TF, Senior B, Wolfdorf JI (1994) Glycogen storage disease in adults. Ann Intern Med 120:218–226PubMed Talente GM, Coleman RA, Alter C, Baker L, Brown BI, Cannon RA, Chen YT, Crigler JF Jr, Ferriera P, Haworth JC, Herman GE, Isseman RM, Keating JP, Linde R, Roe TF, Senior B, Wolfdorf JI (1994) Glycogen storage disease in adults. Ann Intern Med 120:218–226PubMed
Zurück zum Zitat Terkivatan T, de Wilt JH, de Man RA, Ijzermans JN (2000) Management of hepatocellular adenoma during pregnancy. Liver 20:186–7PubMedCrossRef Terkivatan T, de Wilt JH, de Man RA, Ijzermans JN (2000) Management of hepatocellular adenoma during pregnancy. Liver 20:186–7PubMedCrossRef
Zurück zum Zitat Thornton P, Douglas J (2010) Coagulation in pregnancy. Best Pract Res Clin Obstet Gynaecol 24:339–52PubMedCrossRef Thornton P, Douglas J (2010) Coagulation in pregnancy. Best Pract Res Clin Obstet Gynaecol 24:339–52PubMedCrossRef
Metadaten
Titel
Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study
verfasst von
Annalisa Sechi
Laura Deroma
Annunziata Lapolla
Sabrina Paci
Daniela Melis
Alberto Burlina
Francesca Carubbi
Miriam Rigoldi
Maja Di Rocco
Publikationsdatum
01.01.2013
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 1/2013
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-012-9490-1

Weitere Artikel der Ausgabe 1/2013

Journal of Inherited Metabolic Disease 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.